They don't want to approve early in case some safety issue raises it's head at the last minute. They are risk adverse and put their career over short term benefits for strangers. We'll hear the result Thursday morning and not before.
Crucial period for Mesoblast as key FDA ruling looms
https://unauthorised investment advice/health/crucial-period-for-mesoblast-as-key-fda-ruling-looms/
Mesoblast (ASX:MSB) Must have biotech stock?
- Forums
- ASX - By Stock
- MSB
- Ann: FDA Advisory Committee Sets Review Date for Remestemcel-L
Ann: FDA Advisory Committee Sets Review Date for Remestemcel-L, page-688
-
- There are more pages in this discussion • 167 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add MSB (ASX) to my watchlist
(20min delay)
|
|||||
Last
$1.45 |
Change
-0.030(2.03%) |
Mkt cap ! $1.655B |
Open | High | Low | Value | Volume |
$1.48 | $1.51 | $1.43 | $6.613M | 4.498M |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
1 | 2482 | $1.45 |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
$1.46 | 27045 | 2 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
1 | 2482 | 1.450 |
2 | 5794 | 1.445 |
6 | 50901 | 1.440 |
4 | 52442 | 1.435 |
5 | 177906 | 1.430 |
Price($) | Vol. | No. |
---|---|---|
1.455 | 27045 | 2 |
1.460 | 64331 | 5 |
1.465 | 35901 | 2 |
1.470 | 54504 | 2 |
1.480 | 132521 | 3 |
Last trade - 16.10pm 18/10/2024 (20 minute delay) ? |
Featured News
MSB (ASX) Chart |